Alpha-1 Antitrypsin Deficiency Treatment Market Analysis: Emerging Therapies and Forecast
The Alpha-1 Antitrypsin Deficiency Treatment Market is positioned for continued innovation as pharmaceutical and biotechnology companies invest in rare-disease research. Market Research Future projects the market to grow at a 13.23% CAGR between 2025 and 2035, reflecting increasing interest in therapeutic development. Gene therapy represents one of the longer-term opportunities. Researchers...
0 Комментарии 0 Поделились 135 Просмотры 0 предпросмотр